Breaking News

Americans Rushed To Buy Heartburn Because Of The Cure For COVID-19


Famotidine heartburn or heartburn relief medicine is being tested for treatment of COVID-19 patients in New York hospitals. Therefore, the American people rushed to buy, leading to "sold out" situation in many major drug stores in the US.

VnExpress reported, information was confirmed by officials in New York on 27/4. The trial was conducted by Feinstein Medical Research Institute of Northwell Health, which operates a network of 23 hospitals in New York City.

At least 187 patients participated in the trial. Results are expected in the next few weeks. Dr Kevin Tracey, president of the Feinstein Institute for Medical Research, said he hoped to recruit an additional 1,200 participants.

“People are hoping for everything they can to oppose nCoV. Therefore this clinical trial is needed. There are many examples in medical history, showing that a drug made for this purpose works for another disease.”
Tracey said.
Dr. Tracey shared that he had an idea to study famotidine after talking with an infectious disease specialist at Massachusetts General Hospital. This colleague once worked with nCoV-infected patients in China. He observed that the poor heartburn survived longer than the rich heartburn. 

He found that poorer people were taking famotidine while wealthy patients tended to take a more expensive drug.
In addition, Florida-based Alool Laboratories used a computer model to make a list of current drugs that can combat nCoV and famotidine that appear at the top of the list.

Tracey said that because theoretically, the structure of famotidine helps it prevent viruses from replicating, similar to the way protease inhibitors are used to treat HIV, against viruses. He said he would set up an independent council to monitor the trial and make decisions about whether to continue using the drug.

People rushed to buy medicine just made the problem more deadlock

Sheet VietTimes said, although Dr. Tracey has urged people not to rush to buy anti-heartburn drug store, but retailers such as Amazon and Walgreens seems "fire line" products.
At Amazon, Pepcid AC and three other generic drugs are now out of stock for sale as of the afternoon of April 27 (US time).

 The company has not yet commented on the incident.
And at CVS - the largest drug store chain in the US - drugs containing famotidine also sold out at most of its stores in New York. Many other cities such as Los Angeles, Chicago, Houston ... also in a state of "sold out" of drugs containing famotidine. CVS has yet to comment.

Walgreens is facing the same situation as CVS, when famotidine-containing drugs are no longer available in most of their stores in many areas; according to Business Insider.
It is still too early to conclude that famotidine is effective in regulating patients with COVID-19 - a disease caused by the new strain of coronavirus - as Dr. Tracey points out.

Even when the researchers proved that the substance worked, patients tested for the drug were given an extremely high dose of famotidine, far more than the amount a person would normally use to treat heartburn.

"You should not go to the pharmacy and buy a pile of heartburn medicine." 
Tracey told CNN.
Science magazine on Sunday published an article saying that researchers are trying to keep the research a secret because of concerns about stockpiling.
"If this is announced too soon, or to the wrong ears, the supply of the drug will evaporate."
Tracey told Science magazine.

And what Mr. Tracey is worried about is actually happening.
The purchase of stockpiling of famotidine-containing drugs is similar to what happened earlier this year with anti-malarial drugs - successfully manufactured in the 1940s - after some influential leaders , including US President Donald Trump and Tesla CEO Elon Musk, said it was effective in maintaining COVID-19 patients.

Just two weeks after the US press talked about the drug hydroxychloroquine, the US Food and Drug Administration (FDA) has reported a shortage of the drug.

"Fear, chaos and panic are bigger threats than a virus strain, especially with a therapy that may not work." 
said Michael Rea, CEO of Rx Saving Solutions. with Business Insider about drugs believed to be able to treat COVID-19.


No comments